IMC Chicago’s Aquestive Therapeutics AQST Stock Holding History

IMC Chicago’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Sell	69,800 -35,200	-34%	-$148K	﹤0.01%	5255
2026 Q1	$436K	Buy	105,000 +45,700	+77%	+$185K	﹤0.01%	4195
2025 Q4	$383K	Buy	+59,300	New	+$370K	﹤0.01%	3648

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

IMC Chicago's AQST Position: Q2 2026 in Review

IMC Chicago opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 13,584 shares worth $56.5K. The stake represents ﹤0.01% of the portfolio and ranks #6133 among its holdings.

184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

IMC Chicago held 13,584 shares of Aquestive Therapeutics worth $56.5K as of Q2 2026.
Aquestive Therapeutics was a new IMC Chicago position in Q2 2026.
Aquestive Therapeutics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #6133 holding.
184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.